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ABSTRACT
Objective: The aim of the present study was to analyze the effect of the aqueous fruit pulp extract of Tamarindus indica L. (tamarind extract) on 
cytochrome P 450 isoform CYP3A4.
Methods: Tamarind extract at different concentrations from 5 to 100 µg/ml was examined for its inhibitory property toward cytochrome P 450 
isoform CYP3A4. The various concentrations of tamarind extract, potassium phosphate buffer, CYP450 reagent, and substrate 7-Benzyloxy-4-
trifluoromethylcoumarin were added to a 96-well plate. The mixtures were preincubated for 20 min at room temperature. The reaction was started 
by a mixture of free constituted substrate and NADP+ and incubated at room temperature for 30–60 min. The reaction was stopped by Tris-HCl buffer, 
pH 10.5. The fluorescent intensities of the products were measured by PerkinElmer Enspire fluorescence reader using an excitation and emission 
wavelength of 405 nm and 460 nm, respectively. Inhibitory concentration (IC50) was calculated by plotting concentrations of tamarind extract against 
the corresponding percentage inhibition.
Results: All the tested concentrations of extract except 5 µg/ml showed good inhibition against CYP3A4 in a dose-dependent manner. The IC50 value 
of tamarind for CYP3A4 inhibitory activity was found to be 27.89 µg/ml.
Conclusion: T. indica aqueous fruit pulp extract exhibited an inhibitory effect on CYP34A, thereby indicating the possibilities of herb-drug interaction 
if these extracts are coadministered with the prescribed drugs that are metabolized by CYP3A4.
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INTRODUCTION
Cytochrome P450 genes are involved in the formation and breakdown 
of various molecules and chemicals within cells [1]. They play an 
important role in the synthesis of many molecules including steroid 
hormones, certain fats, and acids used to digest fats in the human body. 
It represents a family of isozymes responsible for the biotransformation 
of many drugs through oxidation [2]. Majority of the isozymes are 
located in the liver. However, extrahepatic metabolism occurs in the 
kidney, skin, gastrointestinal tract, and lungs.
Medicinal plants are a rich source of bioactive natural products in most 
precise and most selective way. Since the mid-19th century, many natural 
products have been purified from plants, and most of them are used as 
active elements of the modern medication. The search of excellent, real, 
inexpensive, and simply accessible natural enzyme inhibitor is one of 
the prime aspects of new drug findings and strategy investigation works 
which are done by the study organizations throughout the world [3]. 
Plants and herbs have been widely consumed in many populations of 
the world mainly as food and for various medicinal benefits. Among 
the various types of bioactive compounds found in plants and herbs, 
phenolic compounds that are secondary metabolites have been widely 
reported as potent antioxidants.
Tamarindus indica which is known as the tamarind tree is a tropical 
tree growing abundantly in tropical rain forests. It is known to possess 
high antioxidant activity due to its phenolic content. The various parts 
of the plant are used for its antimicrobial, hepatoprotective, anticancer, 
analgesic, anti-inflammatory, and antiasthmatic property [4,5]. In 
African sub-Saharan populations, T. indica is reported to be the most 
useful tree which serves as ethnomedicine for humans and veterinary 
field and also has cultural uses [6].
When drugs are administered orally, some of them are significantly 
inactivated due to the extensive first-pass metabolism in the 
gastrointestinal tract by the CYP3A4 isozyme. The drug breakdown 
which takes place through the cytochrome P450 system has emerged 
as an important determinant in the occurrence of several drug-drug 
interactions. A greater degree of drug interaction predictability has 
been achieved through the identification of the P450 isozymes and 
a few other drugs that share them. CYP3A4 isozyme has resulted in 
several clinically significant drug-drug interactions. In this study, the 




The aqueous fruit pulp extract of tamarind was obtained from Synthite 
Industries Pvt. Ltd., Kerala, as a gift sample.
Chemicals
CYP450 reagent, 7-Benzyloxy-4trifluoromethylcoumarin (BFC), Tris-
HCl buffer, and potassium phosphate buffer were used. All the chemicals 
used were of analytical grade.
Inhibitory effect of cytochrome P 450 enzyme activity (CYP3A4)
Tamarind extract at different concentrations from 5 to 100 µg/ml was 
examined for its inhibitory property toward cytochrome P 450 isoform 
CYP3A4. The various concentrations of tamarind, potassium phosphate 
buffer, CYP450 reagent, and substrate BFC were added to a 96-well 
plate. The mixtures were preincubated for 20 min at room temperature. 
The reaction was started by a mixture of free constituted substrate and 
NADP+ and incubated at room temperature for 30–60 min. The reaction 
was stopped by Tris-HCl buffer, pH 10.5. The fluorescent intensities 
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of the products were measured by PerkinElmer Enspire fluorescence 
reader using an excitation and emission wavelength of 405 nm 
and 460 nm, respectively [7]. Inhibitory concentration (IC50) was 
calculated by plotting concentrations of tamarind extract at different 
concentrations from 5 to 100 µg/ml which was examined against the 
corresponding percentage inhibition. Values are expressed as mean ± 
standard error of the mean (n=3).
RESULTS
All the tested concentrations of extract except 5 µg/ml showed potent 
inhibition against CYP3A4 in a dose-dependent manner. The IC50 value 
of tamarind for CYP3A4 inhibitory activity was found to be 27.89 µg/ml. 
The extract showed a dose dependant inhibitory effect on different 
concentrations. At 10 µg/ml, the percentage inhibition was found to be 
5.70±4.08; at 20 µg/ml, it was found to be 18.35±2.75; at 40 µg/ml, it 
was found to be 27.12±0.20; at 60 µg/ml, it was found to be 39.77±0.57; 
at 80 µg/ml, it was found to be 50.00±0.28; and at 100 µg/ml, it was 
found to be 62.49±0.65 (Fig. 1).
DISCUSSION
In this study, the extract showed a dose-dependent inhibitory effect on 
CYP3A4 showing the possibility of drug interaction when administered 
with drugs which are metabolized by this particular enzyme and the 
IC50 value of tamarind extract was found to be 27.89 µg/ml.
The cytochrome p450 enzymes play a vital role in the Phase 1 
metabolism, and they are involved in the detoxification, oxidation, and 
elimination of toxins and drugs. Many plants and fruits are proven to 
produce various enzyme inhibitory effect. Grapefruit and star fruit 
extracts are few examples of fruit extracts causing potent inhibition of 
cytochrome P450 enzymes [8,9].
The extracts of Hyptis suaveolens (HS) and Boerhavia diffusa (BD) 
which are medicinal plants used widely to treat eczema, boils, 
and malaria were shown to produce activity on drug metabolizing 
enzymes, CYP1A2, CYP2D6, and CYP3A4. BD was found to be the 
most potent on CYP3A4 (7.36±0.94 µg/mL) compared to both 
CYP2D6 (17.79±1.02 µg/mL) and CYP1A2 (9.48±0.78 µg/mL) in 
comparison with HS CYP1A2 (3.68±0.10 µg/mL) being the least 
inhibited by HS compared to CYP2D6 (1.39±0.01 µg/mL) and 
CYP3A4 (2.36±0.57 µg/mL) [10].
In a study by Higdon and Frei, catechin and epicatechin detected in 
tea prevented oxidative stress in rats’ liver by directly altering the 
subcellular ROS production, glutathione metabolism, and cytochrome 
P450 2E1 activity [11]. Eugenia jambolana Lam fruit is very popular 
for its antidiabetic property, and in a study, it showed its effect on 
various cytochrome P450 enzymes. It showed the differential effect 
on cytochrome P450 activities with an order of inhibitory potential 
as CYP2C9>CYP3A4>CYP2D6 having IC50 of 76.69, 359.02, and 
493.05 µg/ml [12]. In earlier studies, the data were consistent compared 
to the IC50 of the selective inhibitors of our study to the particular CYPs 
reported earlier [6,13-17]. The concentration-inhibition curves of the 
medicinal plants Phyllanthus amarus and Phyllanthus emblica aqueous 
extracts on CYP3A4 activities were observed that P. amarus aqueous 
extract possessed inhibitory effects on CYP3A4 with IC50 of 74.30±1.21, 
34.80±0.34, 180.40±2.53, 49.41±0.52, and 2.07±0.03 µg/mL, respectively. 
P. emblica aqueous extract demonstrated inhibitory effects on CYP3A4 
with IC50 of 310.27±5.07, 194.72±2.94, 589.52±14.32, 310.27±15.06, 
and 325.54±7.44 µg/ml. In our study, we also found that the IC50 value of 
tamarind for CYP3A4 inhibitory activity was found to be 27.89 µg/ml and 
showed increased inhibitory activity as the concentration of the aqueous 
tamarind fruit pulp extract was added in increments.
Apart from intake of a product and looking into its safety and 
effectiveness, attention should be paid to the potential that these 
product ingredients may interact with medications [17,18] as many 
plant products are useful in treating various disease conditions 
such as diabetes mellitus, anxiety, cancer, and many other health 
problems [19-22]. Hence, proper care should be taken to administer 
such products after confirming its effect on various metabolizing 
enzymes. In developing countries, a large population depends on 
herbal medicine for prevention, cure, and mitigation of disease. The 
simultaneous use of herbs may mimic, magnify, or oppose the effect of 
drugs. It is necessary to conduct such studies to avoid unwanted drug 
interactions.
Herbals are capable of interacting with prescribed medications when 
they are taken together at the same time and can lead the patients to 
high risk. The interactions include drug metabolizing enzymes and 
drug transporters. Interactions between herbal remedies and drugs 
lead to the loss of therapeutic efficacy and toxic effects. Pharmacists 
and other health-care providers must be taking an active role in 
learning about herbals and other dietary supplements to avoid herb-
drug interactions [23]. Precautions must be taken as various extracts 
and juices which are consumed daily life to avoid inhibitory potential 
toward these enzymes [24]. In addition, any suspected herbal drug 
interactions should immediately be reported to the Food and Drug 
Administration’s Adverse Event Reporting Program.
CONCLUSION
The aqueous fruit pulp extract of T. indica exhibited an inhibitory effect 
on CYP34A, thereby indicating the possibilities of herb-drug interaction 
if these extracts are coadministered with the prescribed drugs that are 
metabolized by CYP3A4.
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